Sage Therapeutics Inc. stock soared more than 70% Thursday to mark its biggest-ever one-day price and percentage gain, after the company reported positive results in a mid-stage trial of a treatment for severe depression that could offer doctors a new mechanism to treat the disease.
Latest posts by Market Watch (see all)
- Chinese content-aggregation app Qutoutiao files for IPO - August 17, 2018
- Avista Healthcare shares rise on deal to acquire Organogenesis - August 17, 2018
- Personal Finance Daily: What you should know about recording your coworkers and an important tax change - August 17, 2018